...
首页> 外文期刊>The National medical journal of India >A GLIMMER OF HOPE FOR PREVENTION
【24h】

A GLIMMER OF HOPE FOR PREVENTION

机译:预防的希望

获取原文
获取原文并翻译 | 示例
           

摘要

I have written in earlier Letters from Chennai about the rural programme of the Kidney Help Trust. Let me refresh your memory, and give you some updated figures. Renal transplantation is the least expensive treatment for end-stage renal disease. It costs about Rs 3.5 lakh (Rs 350 000) and the patient will then need immunosuppressive therapy costing at least Rs 10 000 a year, which could go up to Rs 1 lakh (Rs 100 000) a year depending on the immunosuppression used. The per capita income in India is Rs 33 283 a year, and only 3.2% of us earn more than Rs 50 000 a year. How do we bridge the gap? The Government (Centre, State and Local together) provides Rs 828 per capita per year on health. It is abundantly clear that India, and most Indians, cannot afford to treat end-stage renal disease.
机译:我在早期的金奈(Chennai)信中写过有关“肾脏帮助信托基金”的农村计划的信。让我刷新您的记忆,并给您一些更新的数字。肾移植是终末期肾脏疾病最便宜的治疗方法。费用约为35万卢比(合35万卢比),然后患者将需要每年至少花费10000卢比的免疫抑制疗法,根据所使用的免疫抑制效果,每年可能高达10万卢比(合10万卢比)。印度的人均收入为每年33283卢比,而我们中只有3.2%的人年收入超过5万卢比。我们如何弥合差距?政府(中心,州和地方政府合计)每年为人均提供828卢比的医疗保健费用。很显然,印度和大多数印度人负担不起治疗晚期肾病的费用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号